KMID : 1141820230230040574
|
|
Journal of Gastric Cancer 2023 Volume.23 No. 4 p.574 ~ p.583
|
|
Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea
|
|
Hong Moon-Ki
Choi Min-Gee Lee Ji-Hyun Kim Kyoo-Hyun Kim Hyun-Wook Lee Choong-Kun Kim Hyo-Song Rha Sun-Young Pih Gyu-Young Choi Yoon-Jin Jung Da-Hyun Park Jun-Chul Shin Sung-Kwan Lee Sang-Kil Lee Yong-Chan Cho Min-Ah Kim Yoo-Min Kim Hyoung-Il Cheong Jae-Ho Hyung Woo-Jin Shin Jae-Yong Jung Min-Kyu
|
|
Abstract
|
|
|
Purpose : Gastric cancer (GC) is among the most prevalent and fatal cancers worldwide. National cancer screening programs in countries with high incidences of this disease provide medical aid beneficiaries with free-of-charge screening involving upper endoscopy to detect early-stage GC. However, the coronavirus disease 2019 (COVID-19) pandemic has caused major disruptions to routine healthcare access. Thus, this study aimed to assess the impact of COVID-19 on the diagnosis, overall incidence, and stage distribution of GC.
Materials and Methods : We identified patients in our hospital cancer registry who were diagnosed with GC between January 2018 and December 2021 and compared the cancer stage at diagnosis before and during the COVID-19 pandemic. Subgroup analyses were conducted according to age and sex. The years 2018 and 2019 were defined as the ¡°before COVID¡± period, and the years 2020 and 2021 as the ¡°during COVID¡± period.
Results : Overall, 10,875 patients were evaluated; 6,535 and 4,340 patients were diagnosed before and during the COVID-19 period, respectively. The number of diagnoses was lower during the COVID-19 pandemic (189 patients/month vs. 264 patients/month) than before it. Notably, the proportion of patients with stages 3 or 4 GC in 2021 was higher among men and patients aged ¡Ã40 years.
Conclusions : During the COVID-19 pandemic, the overall number of GC diagnoses decreased significantly in a single institute. Moreover, GCs were in more advanced stages at the time of diagnosis. Further studies are required to elucidate the relationship between the COVID-19 pandemic and the delay in the detection of GC worldwide.
|
|
KEYWORD
|
|
COVID-19, Stomach neoplasms, Gastric cancer, Incidence
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|